Clinical Trial Update: Evaluation of Clinical Benefit and Safety Following CYFENDUS Administration for Post-Exposure Prophylaxis of Anthrax Disease.

View source ↗

Summary

This clinical trial is evaluating the clinical benefit and safety of CYFENDUS for post-exposure prophylaxis of anthrax and is currently not yet recruiting.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Anthrax

Drugs mentioned

• CYFENDUS

Snippet

Sponsor: Emergent BioSolutions | Conditions: Anthrax | Status: NOT_YET_RECRUITING